AON
36
4
HD
37
2
GD
41
2
LNC
28
-2
TXN
38
3
PM
56
2
HIG
48
4
NFLX
59
-2
EXR
37
15
APH
58
5
FSLR
57
-4
CRM
59
4
MRK
30
-3
RHI
40
-3
R
55
3
PNR
53
3
PPL
49
2
SLB
37
-4
WEC
48
7
MU
52
-6
AON
36
4
HD
37
2
GD
41
2
LNC
28
-2
TXN
38
3
PM
56
2
HIG
48
4
NFLX
59
-2
EXR
37
15
APH
58
5
FSLR
57
-4
CRM
59
4
MRK
30
-3
RHI
40
-3
R
55
3
PNR
53
3
PPL
49
2
SLB
37
-4
WEC
48
7
MU
52
-6
Financhill
Back

KalVista Pharmaceuticals Vs. Janux Therapeutics Industry Stock Comparison

Sell
15

KALV
KalVista Pharmaceuticals

Last Price:
$8.23
Seasonality Move:
-3.06%
Sell
23

JANX
Janux Therapeutics

Last Price:
$50.53
Seasonality Move:
80.32%
Sell
15
KalVista Pharmaceuticals (KALV) is a Sell

Is KalVista Pharmaceuticals a Buy, Sell or Hold?

  • The current KalVista Pharmaceuticals [KALV] share price is $8.24. The Score for KALV is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
  • KALV is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
23
Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics a Buy, Sell or Hold?

  • The current Janux Therapeutics [JANX] share price is $50.82. The Score for JANX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • JANX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KALV Stock Price Chart

What is KalVista Pharmaceuticals's stock price today?

  • The KalVista Pharmaceuticals share price today is $8.24
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KALV is experiencing selling pressure, which indicates risk of future bearish movement.

JANX Stock Price Chart

What is Janux Therapeutics's stock price today?

  • The Janux Therapeutics share price today is $50.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.

KALV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.3 Sell
Relative Strength Index (14 RSI): 39.45 Sell
Chaikin Money Flow: -168429 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.42 - 9.28) Sell
Bollinger Bands (100): (9.25 - 12.13) Sell

JANX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 41.88 Sell
Chaikin Money Flow: -1994706 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.74 - 62.68) Sell
Bollinger Bands (100): (44.76 - 56.7) Buy

KALV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.62 Sell
20-day SMA: 8.7 Sell
50-day SMA: 9.66 Sell
200-day SMA: 11.46 Sell
8-day EMA: 8.62 Sell
20-day EMA: 8.82 Sell
50-day EMA: 9.54 Sell
200-day EMA: 10.94 Sell

JANX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.68 Sell
20-day SMA: 56.78 Sell
50-day SMA: 54.64 Sell
200-day SMA: 47.7 Buy
8-day EMA: 54.12 Sell
20-day EMA: 55.17 Sell
50-day EMA: 54.12 Sell
200-day EMA: 45.19 Buy

KalVista Pharmaceuticals Earnings Growth & KALV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.15 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.60 per share, and an increase next year of $0.87 per share.

Janux Therapeutics Earnings Growth & JANX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and a decrease next year of $0.75 per share.

KalVista Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Janux Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):